Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 3/20 | 0.47 |
| ▸ | LIPC | P11150 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 5/20 | 0.40 |
| ▸ | SCN9A | Q15858 | 4/20 | 0.40 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.40 |
| ▸ | ACACB | O00763 | 1/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28009611 | 0.81 | ALDH1A1 (0.41) | EPHX2 | |
| SCHEMBL27792539 | 0.79 | RBP4 (0.42) | — | |
| SCHEMBL28237166 | 0.78 | EPHX2 (0.42) | EPHX2GRIN1GRIN2BACACB | |
| SCHEMBL28078708 | 0.77 | CHRM3 (0.41) | SCN9AACACB | |
| SCHEMBL16434828 | 0.77 | USP30 (0.52) | LIPG | |
| SCHEMBL27721841 | 0.76 | CHRM3 (0.49) | EPHX2ACACB | |
| SCHEMBL27911300 | 0.76 | CHRM3 (0.49) | EPHX2ACACB | |
| SCHEMBL27874081 | 0.76 | CHRM3 (0.49) | EPHX2ACACB | |
| SCHEMBL28328550 | 0.74 | EPHX2 (0.46) | EPHX2GRIN1GRIN2B | |
| SCHEMBL27037272 | 0.74 | LIPG (0.39) | LIPGLIPCEPHX2ACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104203928-A | Triazinone compound and T-type calcium channel inhibitor | NISSAN CHEMICAL IND LTD | 2014-12-10 | — | — | CN | disclosed |